Rucaparib
Back to searchMolecule Structure
Scientific Name
Rucaparib
Description of the Drug
Rucaparib is a poly (ADP-ribose) polymerase (PARP) inhibitor used to treat recurrent ovarian and prostate cancers in previously treated adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12332
http://www.drugbank.ca/drugs/DB12332
Brand Name(s)
Not Available
Company Owner(s)
Clovis Oncology Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| PARP 1, 2 and 3 | PROTEIN FAMILY | INHIBITOR | CHEMBL3390820 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL844585 | ||
| PharmGKB | PA166163418 | ||
| Human Metabolome Database | HMDB0257361 | ||
| DrugBank | DB12332 | ||
| PubChem: Thomson Pharma | 16463842 | ||
| PubChem | 9931954 | ||
| LINCS | LSM-4947 | ||
| Nikkaji | J2.564.160D | ||
| PDBe | RPB | ||
| BindingDB | 50446130 | ||
| EPA CompTox Dashboard | DTXSID10182563 | ||
| DrugCentral | 5203 | ||
| Brenda | 252856 | ||
| ChemicalBook | CB51475507 | ||
| Guide to Pharmacology | 7736 | ||
| rxnorm | RUCAPARIB | RUBRACA | RUCAPARIB CAMSYLATE |
| ChEBI | 134689 | ||
| ZINC | ZINC000000025958 |
